Rare Disease Challenge (RaDiChal) - Using CRISPR Technology to Cure Rare Diseases

Join a 19-minute webinar presentation by Prof. Cihan Taştan, PhD, exploring the innovative Rare Disease Challenge (RaDiChal) initiative that aims to develop treatments for rare diseases using CRISPR gene editing technology. Learn from an expert who graduated with honors from METU's Molecular Biology and Genetics department and earned his PhD from New York University, specializing in immune system cells and bacterial interactions. Discover how CRISPR's precise gene modification capabilities offer new hope for treating rare medical conditions that traditionally have limited therapeutic options. Gain insights from Prof. Taştan's extensive experience, including his work at The Jackson Laboratory-Genomic Medicine Institute developing CRISPR genome modification techniques and his role as R&D Unit Manager at Acıbadem LabCell Cell Laboratory working on genetically modified CAR-T cell therapies for cancer treatment.